| S-GBOXIN |
S-GBOXIN |
2101317-21-7 |
| AWZ1066S |
AWZ1066S |
2239272-16-1 |
| BI 01383298 |
BI 01383298 |
2227549-00-8 |
| 2-((3S,5R)-3,5-dimethylpiperazin-1-yl)benzo[4,5]imidazo[1,2-a][1,8]naphthyridine-6-carbonitrile |
2-((3S,5R)-3,5-dimethylpiperazin-1-yl)benzo[4,5]imidazo[1,2-a][1,8]naphthyridine-6-carbonitrile |
1822358-25-7 |
| V-9302 |
V-9302 |
1855871-76-9 |
| ME401 |
ME401 |
1595129-71-7 |
| WYC-209 |
4,5-二(羟甲基)-2-苯基-1H-咪唑 |
2131803-90-0 |
| 2-(5-fluoro-2-hydroxyphenyl)-2-(1-oxo-6-(4-(piperazin-1-yl)phenyl)isoindolin-2-yl)-N-(thiazol-2-yl)acetamide |
CPD3616 |
2140807-05-0 |
| Cav 2.2 blocker 1 |
CAV 2.2 BLOCKER 1 |
1567335-29-8 |
| MCHr1 antagonist 2 |
863115-70-2 |
863115-70-2 |
| KAN0438757 |
KAN0438757 |
1451255-59-6 |
| ARRY382 |
ARRY382 |
1313407-95-2 |
| Benzonitrile, 4-[1-[5-[5-(methoxymethyl)-2-(trifluoromethyl)-1H-imidazol-4-yl]-2,4-dimethylbenzoyl]-3-azetidinyl]- |
TVB-3664 |
2097262-58-1 |
| BTdCPU |
BTdCPU |
1257423-87-2 |
| iGOT1-01 |
化合物IGOT1-01 |
882256-55-5 |
| BMS-P5 |
BMS-P5 |
1550371-22-6 |
| UCB-9260 |
UCB-9260 |
1515888-53-5 |
| X77 rac |
X77 rac |
2144491-78-9 |
| Benzenemethanol, 2-[4-amino-6-[[(4-phenoxyphenyl)methyl]amino]-1,3,5-triazin-2-yl]-3-fluoro- |
化合物MS48107 |
2375070-79-2 |
| LOXO-101 (sulfate) |
(3S)-N-[5-[(2R)-2-(2,5-二氟苯基)-1-吡咯烷基]吡唑并[1,5-A]嘧啶-3-基]-3-羟基-1-吡咯烷甲酰胺硫酸盐 |
1223405-08-0 |
